Cargando…
Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
BACKGROUND: The pandemic has changed many aspects of healthcare, including the treatment of people with opioid use disorder with buprenorphine. Prior to the pandemic, rural health disparities existed in the accessibility of this treatment. Rural and frontier areas of the United States, particularly...
Autor principal: | McFadden, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052936/ https://www.ncbi.nlm.nih.gov/pubmed/37065774 http://dx.doi.org/10.1016/j.dadr.2023.100155 |
Ejemplares similares
-
Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023) -
Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023) -
The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022) -
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022) -
COVID-19 pandemic and herd behavior: Evidence from a frontier market
por: Nguyen, Huu Manh, et al.
Publicado: (2023)